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Summary 
~" and r/chains of the T  cell antigen receptor (TCR) complex and the y  chain of Fc receptors 
(FcRy) constitute a family of proteins important for the expression of, and signal transduction 
through, these receptors in hematopoietic cells. In ~'-deficient mice, TCR expression was reduced 
in most T cells. By contrast, CD8oto~  + TCR-~//5 + intestinal intraepithelial lymphocytes in these 
mice expressed a normal level of TCR. Biochemical analysis of the TCR complex in these cells 
from ~'-deficient as well as normal mice revealed the predominant usage of FcRy. Furthermore, 
y/5 + T  cells in epithelia of the skin and female reproductive organs from g'-deficient mice also 
showed relatively high  TCR  expression,  indicating the usage of FcRq/.  These observations 
demonstrate the preferential usage of FcR3' by 3'/c5 § T cells localized in epithelia of normal mice. 
T  cells recognize antigen bound to the products of MHC 
on APC through TCR, and are activated to exert var- 
ious effector functions (1, 2). The TCR complex is a multi- 
meric complex composed of three groups of proteins;  the 
TCR-c~/fl  (or -y/5)  dimer, the CD3 complex, and the ~" 
family of disulfide-linked dimers (3). TCR dimers are respon- 
sible for antigen binding, whereas the other molecules are 
thought to be important for transmembrane signaling. 
The ~" family has three known members, g', ~/, and FcR~/ 
(4-6).  In thymocytes and peripheral T  cells, most of TCR 
complexes contain ~-homodimers, whereas 5-10% of TCRs 
associate with the g'-7/heterodimer. On the other hand, the 
TCR complex in a minor population of T  cells has ~" and 
~/as a form of heterodimers with FcRy (4,  5).  Moreover, 
it is reported that FcR3' was exclusively associated with TCR 
in in vitro cultured large granular lymphocytes (6). 
A considerable body of evidence shows the importance of 
~'both in assembly and surface expression of the TCR com- 
plex and in receptor-mediated signal transduction (7-13).  Cy- 
toplasmic tails of ~" family as well as CD3 molecules have 
consensus motifs important for intracellular signal transduc- 
tion (14, 15). Recent studies indicate that the TCR complex 
has two signal transduction modules, the ~" family dimer and 
the CD3 complex, and that the two modules could trans- 
duce distinct signals  into the cells (15,  16).  In addition, it 
has been reported that the TCR complex containing FcR3' 
has a different signaling capacity from those containing ~" 
(17-19).  Consequently, differential usage of ~" family mole- 
cules by distinct subsets  of T  cells may reflect difference in 
lineage and/or function of these cells. 
Recently, we and others demonstrated that ~" is critical for 
normal T cell development and function, using mice deficient 
in the expression of ~" (20,  21).  We also showed that ~  is 
not so efficient in assembly and surface expression of TCR 
complexes as ~" (20).  Biochemical analysis of T  hybridoma 
ceils revealed  that  this was caused by retention in the en- 
doplasmic reticulum of q-containing TCR complexes (22). 
Taking advantage of the mice lacking ~" (sr'T/~'T mice) (20), 
we evaluated FcRy usage by various subsets of T  cells. 
Materials and Methods 
Mice.  C57BL/6 and KSN nu/nu mice (23) were purchased from 
Japan SLC, Inc. (Hamamatsu, Japan). ~q" mice (20) were bred in 
our facility. 
Cell Preparation.  Single cell suspensions of thymocytes and 
splenocytes  were prepared in RPMI 1640 supplemented with 10% 
heat-inactivated FCS, 2 mM glutamine,  50/xM 2-ME, and 100 
#g/mI kanamycin. Splenocytes were depleted of erythrocytes by 
lysis. For enrichment of CD4-8-  double-negative (DN) thymo- 
cytes, thymocytes were incubated with culture supernatant of anti- 
CD4 mAb (MT4), plated on plastic dishes precoated with rabbit 
anti-mouse immunoglobulin  (Cappel Laboratories, Cochranville, 
PA),  and  nonadherent  cells were  collected  as  DN  thymo- 
cytes-enriched population.  Intestinal intraepithelial lymphocytes 
(i-IEL), hepatic lymphocytes, lymphocytes in mucosal epithelia of 
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Figure  1.  Expression  ofTCR-cdB and-'y/8 
dimers on thymocytes, splenocytes,  and i-IEL 
from ffr/~'T mice. (.4) CD3e and TCR/3 or 
TCR8 expression  on the surface  of thymocytes, 
splenocytes, and i-IEL were examined as de- 
scribed in Materials and Methods. (B) CD4, 
CD8, and TCR(5 expression on the surface of 
i-IEL were analyzed. CD4/CDfc~ or CDfc~/ 
CDf/~ were used to divide  i-IEL into four sub- 
populations (top). The histograms shown  below 
represent the fluorescence  intensity for TCR-(5 
detected  by the third fluorescence,  within each 
quadrant. 
the  female  reproductive  tract  (r-IEL),  and  Thy-1 +  dendritic 
epidermal T  cells (DETC) were isolated  as previously described 
(24-27). 
Flow Cytometric Analysis.  Cells from the thymus, spleen, pe- 
ripheral blood, liver, i-IEL, DETC, and r-IEL were stained  with 
mAbs recognizing CD3e,  TCR-c~//~,  TCR-y/(5, CD4,  CD8c~, 
CD8/~,  and IL-2R/3, and the surface expression of these molecules 
was analyzed on a FACScan |  flow cytometer (Becton Dickinson 
& Co., Mountain View, CA). The following mAbs were used: PE- 
conjugated anti-CD4 (GK1.5) and FITC-labeled anti-CD8c~  (53- 
6.7), purchased from Becton Dickinson & Co., FITC-conjugated 
or biotinylated anti-CD3e  (145-2Cll);  biotinylated anti-TCR-/~ 
(H57-597), biotinylated anti-TCR-y/~i (GL3); and PE-labeled anti- 
CD45R/B220 (RA3-6B2) from PharMingen (San Diego, CA); bi- 
otinylated anti-IL-2R~ (TM-/31) was kindly provided by Dr. M. 
Miyasaka (Tokyo Metropolitan Institute of Medical Science, Tokyo, 
Japan).  Biotinylated mAbs were developed with streptavidin-PE 
(Becton Dickinson & Co.) or streptavidin-Tri-Color  |  (Caltag Labora- 
tories,  San Francisco,  CA). Dead cells were excluded by staining 
with propidium iodide.  Cells in the lymphocyte gate defined by 
light scatter were collected. 
Cell Surface  Biotinylation, Immunoprecipitation,  and Two-dimensional 
SDS-PAGE Analysis.  Cell surface biotinylation was performed as 
previously described (28). Cells were then solubilized in lysis buffer 
(1% digitonin, 50 mM Tris-HC1, pH 7.6,300 mM NaC1, 10/~g/ml 
aprotinin, 10/xg/ml leupeptin,  1 mM PMSF,  10 mM iodoaceta- 
mide) at a concentration of 10  s cells/ml.  Immunoprecipitation was 
performed with anti-TCR-~ mAb (3A10), anti-TCR-/~ mAb (H57- 
597), anti-~"  mAb (H146.698-A),  and anti-FcR'y antiserum, which 
were kindly provided by Drs. S. Tonegawa  (Massachusetts  Insti- 
tute of Technology, Boston, MA), R. Kubo (Cytel Corporation, 
San Diego, CA), and C. Ra (Juntendo University, Tokyo, Japan), 
respectively. Immunoprecipitates were resolved by two-dimensional 
nonreducing-reducing SDS-PAGE (14% for the first dimension and 
16% for the second dimension), transferred onto polyvinylidene 
fluoride membrane (Immobirom-P~;  Millipore Corp.,  Bedford, 
MA). Membranes were soaked in skim-milk in PBS, and biotinylated 
proteins  were  detected  using  streptavidin-peroxidase  (VECTA- 
STAIN |  Elite ABC kit; Vector Laboratories Inc., Burlingame,  CA) 
and ECL  |  system (Amersham International, Buckinghamshire, 
England). 
Results and Discussion 
The expression levels of TCR on thymocytes and periph- 
eral T  cells were significantly reduced in s~T/sr'I  ' mice (20). 
366  Differential  Usage of ~" Family Dimers by Different T Cell Subsets Figure  2.  Biochemical  analysis  of the surface  TCR composition. 
(A) Total and (B) DN-enriched thymocytes  from wild type mice, 
i-IEL from (C and D) C57BL/6 (+/+) mice, (E) KSN nu/nu mice, 
and (F) ~'T/~'T  mice  were surface  biotinylated,  lysed,  and the TCR. 
complex  was immunoprecipitated  with (A and C) anti-TCR-/~  mAB 
(H57-597), or B, D,  E,  and F) anti-TCR-8 mAb (3A10). Im- 
munoprecipitates were separated  by two-dimensional  nonreducing- 
reducing SDS-PAGE, transferred onto PVDF membrane, and bi- 
otinylated proteins were detected as described in Materials and 
Methods. Positions  of ~'-~"  (t), ]'-FcR~ ( i ), and FcRT-FcR7 (A) 
dlmers  are indicated.  Note  that  heterodimers  of  1,12 (35. and Kuwabara, 
I., and Saito, T., manuscript in preparation) with ~" and FcR  7 are 
observed in some  panels. In three experiments (including  E), den- 
sitometric analysis  showed that the mean of the FcR7 of ~'-FcR7 
dimers/FcR3,  of FcRT-FcR.  Y  dimers  is 1:11.9. Considering  that the 
molar ratio of ~" and FcR7 in ~'-FcR7 dimers is 1, the expression 
level of FcR7 molecules is 13 times more than that of ~'. 
This was observed in both oe/3 + and 3,/8 + thymocytes as 
well as splenic T  cells (Fig.  1 A). These data indicate that 
those cells predominantly express  ~" as a component of the 
TCR complex, and extended to normal T cells the previous 
observation on in vitro cell lines that the expression  of ~" is 
critical for a normal level of surface TCR expression  (7-10). 
When we analyzed i-IEL, however,  a striking difference 
was observed (Fig. 1 A) (20). Similar to thymocytes and pe- 
ripheral T cells, surface TCR expression of oe/3 + i-IEL was 
impaired by the ~'T mutation. By contrast, surface TCR. level 
of 9//8 + i-IEL from ~'T/~'T mice was comparable with that 
of 9//8 + i-IEL from wild type mice. In 9//8 + i-IEL, two dis- 
tinct subpopulations are known;  the major population of 
CD8~oe-bearing cells and the minor DN cells. The former 
is thought to differentiate extrathymicaUy, whereas the latter 
is believed to derive from the thymus (29).  Whether TCR 
expression of both 7/8 + i-IEL populations was resistant to 
the ~'T mutation was analyzed by three-color flow cytom- 
etry. As shown in Fig.  1 B, the expression level of surface 
TCR in CD8otot + 9/18 + i-IEL from ~'T/~'T mice remained 
normal, but  that in DN  9//8 + i-IEL was reduced.  These 
observations  suggest that, in CD8otc~  + 3,/8 §  i-IEL, ~" family 
molecules  other  than  ~"  were  predominantly  associated 
with TCR.. 
To test this possibility, various preparations of T cells were 
analyzed for their composition of TCR complexes by a sen- 
sitive  surface biotinylation (28)  and two-dimensional non- 
reducing-reducing SDS-PAGE.  TCR  on  ol/3 +  and 718 + 
thymocytes as well as c~/B + i-IEL from wild type mice was 
predominantly associated with ~'-~"  homodimers (Fig. 2, A-C). 
By contrast, analysis of TCR complexes  on 7/8 + i-IEL re- 
vealed that, on these cells, both ~" and FcR3, contribute for 
TCR constitution (Fig. 2 D). Identification of ~" and FcR9/ 
was confirmed by direct precipitation of  these molecules with 
anti-~"  mAb (H146.968A) and anti-FcR3" antiserum, respec- 
tively (data not shown). Existence of two subpopulations in 
7/8 +  i-IEL  from  normal  mice  as  mentioned above  may 
complicate the analysis. To avoid this complexity, we utilized 
3,/8 + i-IEL from nude mice, which consist exclusively  of 
CD8olo~  + cells (Ohno, H., unpublished observation). The 
result was more striking; these cells predominantly utilize 
FcR7 as TCR subunits, and ~"  homodimers were hardly seen 
(Fig.  2 E).  Assuming that the labeling efficiency of FcR3" 
is comparable between FcR9/homodimers and FcRT-~" het- 
erodimers, these cells express 13 times more FcR7 molecules 
than ~- in TCR (see legend to Fig. 2).  It is likely that DN 
718 + i-IEL, like 718 + thymocytes, predominantly utilize ~" 
based on the following reasons:  the amount of precipitated 
~" from 7/8 + i-IEL from normal mice was much higher than 
that from nude mice;  and TCI~ expression  in DN  3,/8 + 
i-IEL from ~'T/~'T mice was reduced. We further examined 
whether  the  predominance  of FcR3,  in  CD8oeot +  3,/8 + 
i-IEL is also observed  in ~'T/~'T mice. Fig. 2 F  shows that 
this was the case. Collectively, these data indicate that the 
normal level of TCR expression  in CD8oe~ + 3,/8 +  i-IEL 
from ~'T/~'T mice correlates the predominant usage of FcR3, 
by TCR in this subset. 
The preferential usage of FcR3, as a TCR component in 
367  Ohno  et al.  Brief  Definitive Report A  Liver 
/ 
--CD3  " 




Figure  3.  Expression  of TCR on hepatic lymphocytes,  r-IEL, and DETC 
from ~T/~T mice. (A) CD3e and IL-2R3 expression on hepatic lympho- 
cytes was analyzed as described  in Materials and Methods. CD3i.qL-2R3  hi 
cells, which are thought to develop  extrathymically in the liver (30), are 
indicated with squares. (B) CD3E and TCR(5 expression  on peripheral blood 
cells, r-IEL, and DETC were examined as described in Materials and 
Methods. 
CD8otcr + TCR 3,/(5 + i-IEL propelled us to analyze other 
T cell subsets for their usage of FcR3,. For this purpose, we 
examined the expression levels of TCR in T cells from ~'T/s~'T 
mice and compared them with those in T  cells from wild 
type mice. Since r/is far less efficient in assembly and surface 
expression of TCR compared with  ~" (20, 22), it is reason- 
able to assume that T  cells whose TCR expression is resis- 
tant to the ~'T mutation utilize FcR3' as a component of the 
TCR complex. Similar to thymocytes and peripheral T cells, 
TCR on CD3inqL-2R3 hi hepatic lymphocytes (30) were re- 
duced in ~'T/~'T mice (Fig.  3 A). By contrast,  surface TCR 
expression of r-IEL and DETC from ~'T/~'T mice remained 
higher than that of peripheral T cells, indicating the predom- 
inant  usage of FcR7 in  these cells  (Fig.  3 B). 
The present study demonstrates that in mice, certain subsets 
of T cells preferentially utilize FcR3,, of ~" family molecules, 
as  a  component  of  the  TCR  complex.  These  include 
CD8oec~ + 3,/8 + i-IEL, r-IEL, and DETC.  It is of note that 
all these T  cells express the TCR-y/5 dimer and are local- 
ized in epithelia. In addition, these cells express a higher level 
of TCR compared with peripheral T cells. These three subsets 
of y/8+  T  cells  are thought  to be phylogenically old and 
to play a part  in the surveillance of body surfaces  that  are 
exposed to the environment  (26, 31, 32). In this respect, it 
is of particular interest that these T  cells commonly utilize 
FcRy as a component of their TCR complexes. FcR'y has 
one signaling  motif in the cytoplasmic portion,  whereas ~" 
has three motifs, which are supposed to be generated by in- 
tramolecular duplication. Furthermore, FcR3, is also expressed 
in NK cells, which are proposed to be the ancestor of T cells 
(33). Taken together,  FcR3~ may be a prototype of ~" family 
molecules. 
Differential usage of ~" and FcR'y by distinct T cell subsets 
likely represents  differences in lineage and/or function of these 
cells. Recently, evidence supporting the idea that TCR with 
FcRy is functionally distinct from TCR with ~" is increasing. 
First,  in vitro kinase assay on immunoprecipitates  of TCR 
complexes containing FcR3~ displayed a distinct phosphory- 
lation pattern from that of TCR complexes containing ~" in 
T hybridoma cells (17). Second, the cytoplasmic tail of ~'but 
not FcR  3, can transduce signals mediated through Thy-1 mol- 
ecules (18). Third, ~'is replaced by FcR3, in T cells from tumor- 
bearing mice as well as cancer patients,  and  the change is 
accompanied with immune incompetence including an im- 
paired antitumor  response (19).  Concerning  the functional 
difference between distinct T  cell subsets, an interesting re- 
sult was reported  in  mucosal immunity  (34);  y/8+  i-IEL 
from mice orally immunized  with antigen  abrogates toler- 
ance induced in recipient mice by oral administration  of the 
same antigen when transferred, while ot/3 + i-IEL provides 
helper function for antibody production in vitro. These func- 
tional  differences may reflect differential usage of ~" family 
molecules by "y/8+ and ot/fl + i-IEL.  Further study should 
shed light on the physiological role ofT cell subsets bearing 
TCR with different  ~" family molecules. 
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References 
1.  Saito, T., A. Weiss, J. Miller, M.A. Norcross, and R.N. Ger- 
main. 1987. Specific  antigen-Ia activation oftransfected human 
T cells expressing murine Ti otfl-human receptor complexes. 
Nature (Lond.). 325:125. 
2.  Davis, M.M., and P.J. Bjorkman. 1988. T-cell antigen receptor 
genes and T-cell recognition.  Nature (Lond.). 334:395. 
368  Differential  Usage of ~" Family Dimers by Different T Cell Subsets 3.  Klausner, R.D., J. Lippincott-Schwartz, and J.S. Bonifacino. 
1990. The T cell antigen receptor: insights into organelle bi- 
ology. Annu.  Rev. Ceil Biol. 6:403. 
4.  Orloff, D.G., C. Ra, S.J. Frank, R.D. Klausner, andJ.-P. Kinet. 
1990. Family of disulfide-linked  dimers containing the ~" and 
~/chains of the T-cell receptor and the y chain of Fc receptors. 
Nature (Lond.). 347:189. 
5.  Vivier,  E.,  N.  Rochet,  J.P.  Kochan,  D.H.  Presky,  S.T. 
Schlossman,  and P. Anderson. 1991. Structural similarity be- 
tween Fc receptors and  T  cell  receptors: expression  of the 
y-subunit of FceRI in human T cells, natural killer cells and 
thymocytes. J. Immunol.  146:4263. 
6.  Koyasu, S., L. D'Adamio,  A.R.N. Arulanandam, S. Abraham, 
L.K. Clayton, and E.L. Reinherz. 1992. T cell receptor com- 
plexes containing FceRIy homodimers in lieu of CD3~" and 
CD3~ components: a novel isoform expressed on large granular 
lymphocytes, j.  Exp.  Med.  175:203. 
7.  Minami,  Y.,  A.M.  Weissman,  L.E.  Samelson,  and  R.D. 
Klausner.  1987.  Building  a  multichain  receptor:  synthesis, 
degradation, and assembly of the T-cell antigen receptor. Proc. 
Natl. Acad. Sci. USA.  84:2688. 
8.  Sussman, J.J., J.S. Bonifacino, J. Lippencott-Schwartz, A.M. 
Weissman,  T. Saito, R.D. Klausner,  and J.D. Ashwell.  1988. 
Failure  to synthesize the T  cell CD3-~" chain:  structure and 
function of a partial T  cell receptor complex. Cell. 52:85. 
9.  Weissman,  A.M., S.J. Frank, D.G.  Orloff, M. Mercep, J.D. 
Ashwell,  and R.D. Klausner.  1989. Role of the zeta chain in 
the expression of the T cell antigen receptor: genetic reconsti- 
tution studies.  EMBO (Eur. Mol.  Biol. Organ.) J.  8:3651. 
10.  Ashwell,  J.D., and R.D. Klausner.  1990. Genetic and muta- 
tional analysis of the T-cell antigen receptor. Annu.  Rev. Im- 
munol. 8:139. 
11.  Irving, B.A., and A. Weiss. 1991. The cytoplasmic domain of 
the T cell receptor ~" chain is sufficient to couple to receptor- 
associated  signal  transduction pathways.  Cell.  64:891. 
12.  Romeo, C., and B. Seed. 1991. Cellular immunity to HIV ac- 
tivated by CD4 fused to T  cell or Fc receptor polypeptides. 
Cell.  64:1037. 
13.  Weiss, A.  1993. T cell antigen receptor signal  transduction: 
a tale of tails and cytoplasmic protein-tyrosine kinases.  Cell. 
73:209. 
14.  Reth,  M.  1989.  Antigen receptor tail  clue.  Nature  (Lond.). 
338:383. 
15.  Wegener, A.-M., F. Letourneur, A. Hoeveler, T. Brocker,  F. 
Luton, and B. Malissen.  1992. The T cell receptor/CD3 com- 
plex is composed of at least  two autonomous transduction 
modules. Cell. 68:83. 
16.  Letourneur, F., and R.D. Klausner.  1992. Activation ofT cells 
by a tyrosine kinase activation domain in the cytoplasmic tail 
of CD3e. Science (Wash. DC).  255:79. 
17.  Ohno, H., T. Aoe, C. Ra, T. Yamamoto, and T. Saito. 1993. 
TCR isoform containing the Fc receptor chain exhibit struc- 
tural and functional differences from isoform containing CD3 ~'. 
Int.  Immunol.  5:1403. 
18.  Letourneur, F., and R.D. Klausner. 1991. T-cell and basophil 
activation through the cytoplasmic tail of T-celt-receptor ~" 
family proteins. Proc. Natl. Acad. Sci. USA.  88:8905. 
19.  Mizoguchi, H., J.J. O'Shea, D.L. Longo, C.M. Loeffier, D.W. 
McVicar, and A.C.  Ocha.  1992.  Alterations in signal  trans- 
duction molecules in T lymphocytes from tumor-bearing mice. 
Science (Wash. DC).  258:1795. 
20.  Ohno,  H.,  T.  Aoe,  S.  Taki,  D.  Kitamura,  Y.  Ishida,  K. 
Rajewsky,  and T. Saito.  1993. Developmental and functional 
impairment of T  cells in mice lacking CD3~" chains. EMBO 
(Eur. Mot.  Biol. Organ.) J.  12:4357. 
21.  Love, P.E., E.W. Shores, M.D. Johnson, M.L. Tremblay, E.J. 
Lee, A. Grinberg, S.P. Huang, A. Singer,  and H. Westphal. 
1993. T cell development in mice that lack the ~" chain of the 
T cell antigen receptor complex. Science (Wash. DC). 261:918. 
22.  Clayton, L.K., A. Diener, A. Lerner, A.G.D. Tse, S. Koyasu, 
and  E.L.  Reinherz.  1992.  Differential regulation  of T-cell 
receptor processing and surface expression affected by CD30, 
an alternatively spliced product of the CD3~'/~7 gene locus. 
J. Biol. Chem.  267:26023. 
23.  Sudo, K., and K. Suzuki. 1987. Establishment of a new inbred 
nude strain,  KSN. Mouse News Lett.  79:13. 
24.  Ishikawa, H., Y. Li, A. Abeliovich, S. Yamamoto, S.H.E. Kauf- 
mann,  and  S.  Tonegawa.  1993. Cytotoxic and  interferon 
y-producing activities  of 3'8 T  cells in the mouse intestinal 
epithelium are strain dependent. Proc. Natl. Acad. Sci. USA. 
90:8204. 
25.  Watanabe,  H.,  K.  Ohtsuka,  M.  Kimura,  Y.  Ikarashi,  K. 
Ohmori, A. Kusumi, T. Ohteki, S. Seki, and T. Abo. 1992. 
Details of an isolation method for hepatic lymphocytes in mice. 
J.  Immunol.  Methods.  146:145. 
26.  Itohara, S., A.G. Farr, J.J. Lafaille, M. Bonneville,  Y. Takagi, 
W. Haas, and S. Tonegawa.  1990. Homing of a ")'8 thymocyte 
subset with homogeneous T-cell receptors to mucosal epithelia. 
Nature (Lond.). 343:754. 
27.  Ota, Y., T. Kobata, M. Seki, Y. Yagita, S. Shimada, Y3  r. Huang, 
Y. Takagi, Y., and K. Ohmura.  1992. Extrathymic origin of 
Vyl/V86  T  cells in the skin.  Eur. J. Immunol.  22:5958. 
28.  Miyake, K., I.L. Weissman, J.S. Greenberger, and P.W. Kin- 
cade. 1991. Evidence for a role of the integrin VLA-4 in lympho- 
hemopoiesis. J. Exp.  Med.  173:599. 
29.  Lefrancois, L. 1991. Extrathymic differentiation ofintraepithelial 
Iymphocytes: generation of a separate and unequal T-cell reper- 
toire? Immunol.  Today. 12:436. 
Abo, T. 1993. Extrathymic pathways of T-cell differentiation: 
a primitive and fundamental immune system.  Microbiol. Im- 
munol. 37:247. 
Janeway, C.A., Jr. 1988. Frontiers of the immune system. Na- 
ture (Lond.). 333:804. 
Janeway, C.A., Jr., B. Jones, and A. Hayday. 1988. Specificity 
and function of T cells bearing 3,8 receptors. Immunol.  Today. 
9:73. 
Rodewald, H.-R., P. Moningeon, J.L. Lucich, C. Dosiou, P. 
Lopez, and E.L. Reinherz. 1992. A population of early fetal 
thymocytes expressing FcRII/III contains precursors ofT lym- 
phocytes and natural killer cells. Cell. 69:139. 
Fujihashi,  K., T. Taguchi, W.K. Aicher, J.R.  McGhee, J.A. 
Blustone, J.H. Eldridge, and H. Kiyono. 1992. Immunoregula- 
tory functions for murine intraepithetial lymphocytes: 7/8 T 
cell receptor-positive (TCR +) T cells abrogate oral tolerance, 
while c~/~  TCR*  T  cells provide B cell help. J. Exp.  Ailed. 
175:695_ 
Aoe, T., H. Ohno, S. Sonta, and T. Saito.  1993. Functional 
inactivation of the CD3~" chain in a T  cell hybridoma by in 
vitro gene targeting. Int.  Immunol.  5:725. 
Malissen, M., A. Gillet, B. Rocha, J. Trucy, E. Vivier, C. Boyer, 
F. Kontgen, N. Brun, G. Mazza, E. Spanopoulou, et al. 1993. 
T cell development in mice lacking the CD3-~'/~ gene. EMBO 








369  Ohno et al.  Brief Definitive Report 